.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,674,798

« Back to Dashboard

Details for Patent: 7,674,798

Title:Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
Abstract: In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.
Inventor(s): Chapman; Robert (North Kingstown, RI), Rider; Lonn S. (Foster, RI), Hong; Qi (Sharon, MA), Kyle; Donald (Newtown, PA), Kupper; Robert (Coventry, RI)
Assignee: Purdue Pharma L.P. (Stamford, CT)
Filing Date:Jan 16, 2007
Application Number:11/653,530
Claims:1. A packaged oxycodone hydrochloride composition comprising a pharmaceutically acceptable package containing at least 1 kg of an oxycodone hydrochloride active pharmaceutical ingredient having less than 25 ppm 14-hydroxycodeinone, wherein at least a portion of the 14-hydroxycodeinone is derived from 8.alpha.,14-dihydroxy-7,8-dihydrocodeinone during conversion of oxycodone free base to oxycodone hydrochloride.

2. The packaged oxycodone hydrochloride composition of claim 1, wherein the 14-hydroxycodeinone is derived solely from 8.alpha.,14-dihydroxy-7,8-dihydrocodeinone.

3. The packaged oxycodone hydrochloride composition of claim 1, wherein the oxycodone hydrochloride active pharmaceutical ingredient has less than 15 ppm 14-hydroxycodeinone.

4. The packaged oxycodone hydrochloride composition of claim 1, wherein the oxycodone hydrochloride active pharmaceutical ingredient has less than 10 ppm 14-hydroxycodeinone.

5. The packaged oxycodone hydrochloride composition of claim 1, wherein the oxycodone hydrochloride active pharmaceutical ingredient has a lower limit of 14-hydroxycodeinone of 0.25 ppm.

6. The packaged oxycodone hydrochloride composition of claim 1, wherein the oxycodone hydrochloride active pharmaceutical ingredient has a lower limit of 14-hydroxycodeinone of 0.5 ppm.

7. The packaged oxycodone hydrochloride composition of claim 1, wherein the oxycodone hydrochloride active pharmaceutical ingredient has a lower limit of 14-hydroxycodeinone of 1 ppm.

8. The packaged oxycodone hydrochloride composition of claim 1, wherein the oxycodone hydrochloride active pharmaceutical ingredient has a lower limit of 14-hydroxycodeinone of 2 ppm.

9. The packaged oxycodone hydrochloride composition of claim 1, wherein the oxycodone hydrochloride active pharmaceutical ingredient has a lower limit of 14-hydroxycodeinone of 5 ppm.

10. The packaged oxycodone composition of claim 1, wherein the oxycodone hydrochloride active pharmaceutical ingredient has less than 5 ppm 14-hydroxycodeinone.

11. The packaged oxycodone hydrochloride composition of claim 1, wherein the amount of the oxycodone hydrochloride active pharmaceutical ingredient in the pharmaceutically acceptable package is between about 10 kg and about 500 kg.

12. The packaged oxycodone hydrochloride composition of claim 1, wherein the amount of the oxycodone hydrochloride active pharmaceutical ingredient in the pharmaceutically acceptable package is between about 20 kg and about 100 kg.

13. The packaged oxycodone hydrochloride composition of claim 1, wherein the amount of the oxycodone hydrochloride active pharmaceutical ingredient in the pharmaceutically acceptable package is between about 20 kg and about 50 kg.

14. The packaged oxycodone hydrochloride composition of claim 1, wherein the pharmaceutically acceptable package is a corrugated box container.

15. The packaged oxycodone hydrochloride composition of claim 1, wherein the pharmaceutically acceptable package is a drum.

16. The packaged oxycodone hydrochloride composition of claim 1, wherein the pharmaceutically acceptable package is a flexible intermediate bulk container.

17. The packaged oxycodone hydrochloride composition of claim 1, comprising a liner between the pharmaceutically acceptable package and the oxycodone hydrochloride active pharmaceutical ingredient.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc